Please login to the form below

Ariad Pharma

This page shows the latest Ariad Pharma news and features for those working in and with pharma, biotech and healthcare.

Angelini to market Ariad’s Iclusig in Eastern Europe

Angelini to market Ariad’ s Iclusig in Eastern Europe. Comes after leukaemia drug passes EMA safety review. ... US pharma company Ariad Pharmaceuticals has licensed its cancer drug Iclusig to Italy-based firm Angelini Pharma to market in 23 Eastern

Latest news

Pfizer faces NICE rejection for cancer drug Bosulif

In April 2013 an article in the journal Blood saw 20 physicians specialising in CML treatment call for price reductions for CML drugs, claiming that Bosulif, Ariad Pharma's Iclusig (ponatinib) ... So far this pressure has been focused on the US, however
Leukaemia drug prices "unsustainable" say cancer experts

The experts single out three new drugs for CML approved by the FDA last year - Pfizer's Bosulif (bosutinib), Ariad Pharma's Iclusig (ponatinib) and Teva's Synribo (omacetaxine) - which they
EU recommendations for Gilead, Ariad and Baxter drugs

Gilead Sciences, Ariad Pharma and Baxter have all received backing from the European Medicines Agency (EMA) to market new treatments. ... Iclusig approved to treat leukaemia. The CHMP also gave a positive opinion to Ariad Pharma for the use of Iclusig

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

How to integrate data to drive sales

Inspired by a recent Agnitio roundtable discussion with Allergan, Ariad Pharmaceuticals, Astellas and Ipsen Pharma.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Home based, Chief Medical Writer, Medical Communications: Excellent package

Home based, Principal Medical Writer, Medical Communications: Excellent package

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Healthcare PR Director: £100, 000 – £120, 000 benefits

Home based, Senior Medical Writer, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Account Manager: £40, 000 - £45, 000 benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Client Services Director - Med Comms: Great salary and bebefits

Client Services Director – Healthcare Advertising - London: Neg

Home based, Editorial Team Leader, Medical Communications: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Delivery Manager/ Head of Delivery – Executive Search: Neg

Business Unit Head, Medical Communications, London: Excellent package

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Subscribe to our email news alerts

PMHub

Add my company

SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....